Cmed, a clinical research organization and technology development company, has entered into a partnership agreement with Tessella, an information technology and consulting services company.
Subscribe to our email newsletter
Under the terms of the agreement, Tessella and Cmed will ensure interoperability of Timaeus, the intelligent data acquisition and management system with Tessella Fates, Tessella’s fixed and adaptive trial execution system.
Tom Parke, head of clinical technologies at Tessella, said: “With Timaeus, organizations have the ability to acquire, manage and report data in near real-time. This is particularly important for adaptive trials because it minimizes the delay in the availability of response data and therefore adaptation of the trial.
“The interoperability of two best of breed clinical trial products represents an important step in removing the operational complexity associated with adaptive clinical trials.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.